drugset
drugset / Trial / NCT00929331

Immunogenicity & Safety Study of Fluviral® (2009 - 2010 Season) in Adults Aged 18 to 60 Years and Over 60 Years

NCT00929331 ↗

Phase 3 Completed 110 enrolled GlaxoSmithKline
Non-randomizedParallel-groupOpen-labelPrevention

Summary

This study is designed to test the safety and immunogenicity of Fluviral® (2009 - 2010 Season) in adults aged 18 to 60 years and over 60 years.

Timeline

Start
2009-07-11
Primary completion
2009-08-01
Completion
2009-08-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluviral Vaccine — Intramuscular

Indications

influenza